Image 1 of 2
Image 2 of 2
Alpha GPC
Alpha GPC – Choline & Cognitive Function Support
Alpha GPC, also known as alpha-glycerylphosphorylcholine or choline alphoscerate, is a choline-containing compound studied for its role in brain and nervous system function. Choline is used by the body to help produce acetylcholine, a neurotransmitter involved in memory, learning, and normal cognitive communication. Human research has mainly studied Alpha GPC in adult-onset cognitive dysfunction, mild cognitive impairment, and selected cognitive performance outcomes in healthy adults.
Potential Health Benefits of Alpha GPC
Supports healthy choline availability for brain and nervous system function
May assist cognitive function in ageing and mild cognitive impairment research
Supports cognitive performance research in selected healthy adult populations
Further Information
Traditional & Historical Use
Alpha GPC is not a traditional herbal ingredient. It is a naturally occurring choline-containing compound found in the body and in small amounts in some foods. Modern use of Alpha GPC developed through research into choline metabolism, acetylcholine production, cognitive function, and neurological health. It has been studied most often in clinical and ageing-related cognitive research rather than traditional medicine systems.
Choline & Neurological Function
Alpha GPC is described in clinical literature as a cholinergic precursor, meaning it contributes choline for acetylcholine-related pathways. Acetylcholine plays a role in learning, memory, attention, and communication between nerve cells, which is why Alpha GPC has been investigated in cognitive function research.
Cognitive Function Research
A 2023 systematic review and meta-analysis evaluated choline alphoscerate in adult-onset cognitive dysfunction and reported positive effects across included cognitive outcomes. The research focused mainly on clinical and ageing-related cognitive populations, including neurological conditions, rather than broad nootropic use in the general population.
Mild Cognitive Impairment Research
A 2024 randomised, double-blind, placebo-controlled trial investigated choline alphoscerate in people with amnestic mild cognitive impairment and reported improvements in cognitive function outcomes over the study period. The trial also assessed safety in this population.
Healthy Adult Cognitive Performance Research
A 2024 randomised crossover trial in young healthy men found that acute Alpha GPC supplementation improved Stroop Test performance, a measure related to attention and cognitive control. This study provides early human evidence in healthy adults, although it was short-term and conducted in a specific population.
Safety & Considerations
Alpha GPC has been used in clinical and supplemental research, but individual suitability may vary. Possible side effects may include headache, dizziness, digestive discomfort, insomnia, or low blood pressure in some people. Observational research has reported an association between Alpha GPC use and increased long-term stroke risk; this type of study cannot prove cause and effect, but it is important for safety awareness. Individuals who are pregnant, breastfeeding, taking prescription medications, or managing neurological, cardiovascular, blood pressure, stroke-risk, or other medical conditions should consult a qualified healthcare professional before use. As with all supplements, use only as directed and seek medical advice before consuming if unsure whether this product is suitable for your individual needs.
References
Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data
https://pubmed.ncbi.nlm.nih.gov/11589921/Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis
https://pubmed.ncbi.nlm.nih.gov/36683513/Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial
https://pubmed.ncbi.nlm.nih.gov/39300341/Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men
https://pubmed.ncbi.nlm.nih.gov/39683633/Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years
https://pmc.ncbi.nlm.nih.gov/articles/PMC8613599/
Alpha GPC – Choline & Cognitive Function Support
Alpha GPC, also known as alpha-glycerylphosphorylcholine or choline alphoscerate, is a choline-containing compound studied for its role in brain and nervous system function. Choline is used by the body to help produce acetylcholine, a neurotransmitter involved in memory, learning, and normal cognitive communication. Human research has mainly studied Alpha GPC in adult-onset cognitive dysfunction, mild cognitive impairment, and selected cognitive performance outcomes in healthy adults.
Potential Health Benefits of Alpha GPC
Supports healthy choline availability for brain and nervous system function
May assist cognitive function in ageing and mild cognitive impairment research
Supports cognitive performance research in selected healthy adult populations
Further Information
Traditional & Historical Use
Alpha GPC is not a traditional herbal ingredient. It is a naturally occurring choline-containing compound found in the body and in small amounts in some foods. Modern use of Alpha GPC developed through research into choline metabolism, acetylcholine production, cognitive function, and neurological health. It has been studied most often in clinical and ageing-related cognitive research rather than traditional medicine systems.
Choline & Neurological Function
Alpha GPC is described in clinical literature as a cholinergic precursor, meaning it contributes choline for acetylcholine-related pathways. Acetylcholine plays a role in learning, memory, attention, and communication between nerve cells, which is why Alpha GPC has been investigated in cognitive function research.
Cognitive Function Research
A 2023 systematic review and meta-analysis evaluated choline alphoscerate in adult-onset cognitive dysfunction and reported positive effects across included cognitive outcomes. The research focused mainly on clinical and ageing-related cognitive populations, including neurological conditions, rather than broad nootropic use in the general population.
Mild Cognitive Impairment Research
A 2024 randomised, double-blind, placebo-controlled trial investigated choline alphoscerate in people with amnestic mild cognitive impairment and reported improvements in cognitive function outcomes over the study period. The trial also assessed safety in this population.
Healthy Adult Cognitive Performance Research
A 2024 randomised crossover trial in young healthy men found that acute Alpha GPC supplementation improved Stroop Test performance, a measure related to attention and cognitive control. This study provides early human evidence in healthy adults, although it was short-term and conducted in a specific population.
Safety & Considerations
Alpha GPC has been used in clinical and supplemental research, but individual suitability may vary. Possible side effects may include headache, dizziness, digestive discomfort, insomnia, or low blood pressure in some people. Observational research has reported an association between Alpha GPC use and increased long-term stroke risk; this type of study cannot prove cause and effect, but it is important for safety awareness. Individuals who are pregnant, breastfeeding, taking prescription medications, or managing neurological, cardiovascular, blood pressure, stroke-risk, or other medical conditions should consult a qualified healthcare professional before use. As with all supplements, use only as directed and seek medical advice before consuming if unsure whether this product is suitable for your individual needs.
References
Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data
https://pubmed.ncbi.nlm.nih.gov/11589921/Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis
https://pubmed.ncbi.nlm.nih.gov/36683513/Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial
https://pubmed.ncbi.nlm.nih.gov/39300341/Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men
https://pubmed.ncbi.nlm.nih.gov/39683633/Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years
https://pmc.ncbi.nlm.nih.gov/articles/PMC8613599/